INmune Bio Inc.
INMB
$1.22
-$0.01-0.41%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 21.36M | 24.75M | 27.73M | 33.37M | 19.34M |
| Total Receivables | 770.00K | 4.54M | 2.46M | 2.16M | 1.42M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 694.00K | 595.00K | 472.00K | 505.00K | 207.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 22.82M | 29.89M | 30.67M | 36.03M | 20.96M |
|
|
|||||
| Total Current Assets | 22.82M | 29.89M | 30.67M | 36.03M | 20.96M |
| Net Property, Plant & Equipment | 2.31M | 1.87M | 1.94M | 1.08M | 278.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | 16.51M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 683.00K | 595.00K | 746.00K | 570.00K | 49.00K |
| Total Assets | 25.82M | 32.35M | 33.36M | 37.68M | 37.80M |
|
|
|||||
| Total Accounts Payable | 4.66M | 7.77M | 6.88M | 7.67M | 7.20M |
| Total Accrued Expenses | 25.00K | 25.00K | 25.00K | 184.00K | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 704.00K | 623.00K | 457.00K | 220.00K | 146.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 511.00K | 583.00K |
| Total Other Current Liabilities | -- | -- | -- | 511.00K | 583.00K |
| Total Current Liabilities | 5.39M | 8.42M | 7.36M | 8.59M | 7.93M |
|
|
|||||
| Total Current Liabilities | 5.39M | 8.42M | 7.36M | 8.59M | 7.93M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 806.00K | 411.00K | 623.00K | 231.00K | 201.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 6.19M | 8.83M | 7.98M | 8.82M | 8.13M |
|
|
|||||
| Common Stock & APIC | 234.80M | 233.30M | 229.92M | 226.93M | 203.13M |
| Retained Earnings | -214.44M | -209.04M | -203.77M | -197.30M | -172.84M |
| Treasury Stock & Other | -727.00K | -737.00K | -764.00K | -763.00K | -610.00K |
| Total Common Equity | 19.62M | 23.52M | 25.38M | 28.87M | 29.67M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 19.62M | 23.52M | 25.38M | 28.87M | 29.67M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 19.62M | 23.52M | 25.38M | 28.87M | 29.67M |
|
|
|||||